Fig. 6
From: Enhancing dendritic cell immunotherapy for melanoma using a simple mathematical model
Simulation of immunotherapy changing the number of DCs doses. Interval injection every 192 hours applying 106 DCs per dose during three weeks (Table 2, Protocol 15) a 37.12 % of decrease was obtained. Tumor population (thick line) and amount of DCs injected (dotted line) are shown